Pharma Mar, S.A. (OTCMKTS:PHMMF - Get Free Report) saw a large growth in short interest in April. As of April 15th, there was short interest totalling 39,600 shares, a growth of 21.1% from the March 31st total of 32,700 shares. Approximately 0.2% of the shares of the stock are sold short. Based on an average daily volume of 100 shares, the short-interest ratio is currently 396.0 days.
Pharma Mar Price Performance
Pharma Mar stock remained flat at $88.18 during trading hours on Tuesday. The company's stock had a trading volume of 41 shares, compared to its average volume of 1,297. The company has a debt-to-equity ratio of 0.14, a quick ratio of 2.01 and a current ratio of 2.55. The firm has a fifty day simple moving average of $93.70 and a two-hundred day simple moving average of $86.13. Pharma Mar has a 12 month low of $26.85 and a 12 month high of $105.60.
Pharma Mar Company Profile
(
Get Free Report)
Pharma Mar, SA, a biopharmaceutical company, engages in the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Italy, Germany, Ireland, France, rest of the European Union, the United States, and internationally. The company operates through Oncology and RNA Interference segments.
Featured Articles
Before you consider Pharma Mar, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Pharma Mar wasn't on the list.
While Pharma Mar currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
